[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Consorci Sanitari de Terrassa\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":289},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,11,0,[8,43,71,94,118,136,160,179,208,238,267],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100508964","immersive-virtual-reality-techniques-on-the-effects-on-cognition-in-people-with-cancer-100508964",false,"NCT05907265","Immersive Virtual Reality Techniques on the Effects on Cognition in People With Cancer","Study of the Benefits of Immersive Virtual Reality Techniques on the Effects on Cognition in People With Cancer (OncoBRAIN)","OncoBRAIN","Inclusion Criteria:\n\nA. Over 18 years of age and under 65 years of age B. Diagnosis of cancer C. At least 4 weeks since the last chemotherapy treatment session D. Presence of cognitive complaints after chemotherapy treatment E. Level of primary education to be able to perform the cognitive tests. F. Consent to participate in the study\n\nExclusion Criteria:\n\nA. Established diagnosis prior to cancer diagnosis of psychiatric, neurological, neurodevelopmental or systemic disorder causing cognitive deficits.\n\nB. Motor or sensory impairments that preclude completion of the program. C. Undergoing chemotherapy treatment","ALL","18 Years","65 Years",{"count":21,"type":22},60,"ESTIMATED","INTERVENTIONAL",[25],"NA","OncoBRAIN aims to assess the effect of an innovative immersive virtual reality-based (IVR) intervention that includes cognitive, physical activity and mindfulness exercises in people diagnosed with cancer and Chemotherapy-Related Cognitive Deficits (CRCD). The main objective of OncoBRAIN is to determine the benefits of RVI intervention on the cognitive, and emotional state and quality of life of people with cancer and CRQD. We hypothesize that in OncoBRAIN we will find improvements in people with cancer and CRCD who have received IVR stimulation compared to the control group with cancer and CRCD who have not received IVR stimulation. People in the experimental group will perform better than patients in the control group in cognition (episodic memory, executive function, attention, and information processing speed), show better emotional well-being and perceive a better quality of life at the end of the intervention.",[28,29],"Cancer","Cognitive Impairment","RECRUITING","2026-04-14",{"date":33,"type":34},"2026-04-17","ACTUAL",{"date":36,"type":34},"2023-05-01",{"date":38,"type":22},"2027-06-30",{"name":40,"class":41},"Consorci Sanitari de Terrassa","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":4,"eligibilityCriteria":49,"healthyVolunteers":50,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":51,"targetDuration":4,"studyType":53,"phases":4,"briefSummary":54,"conditions":55,"keywords":57,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":70},"100477983","antihistamines-amantadine-and-evolution-of-covid-19-100477983","NCT05504057","Antihistamines, Amantadine and Evolution of COVID-19","Evaluation of Treatments With Antihistamines and Amantadine in the Evolution of the SARS-CoV-2 Infection","Inclusion Criteria: Patients having chronic treatment with antihistamines or amantadine -\n\nExclusion Criteria: None\n\n\\-",true,{"count":52,"type":22},140660,"OBSERVATIONAL","The rates of symptomatic COVID19 infection, hospital admission among COVID19 cases and survival would be quantified in patiens chronically treated with antihistamines or amantadine, with the aim of determining the role of antihistamines and amantadine in the evolution of COVID19.",[56],"COVID-19",[58,59,60,61],"antihistamines","amantadine","hospital admissions","survival","2026-03-30",{"date":64,"type":34},"2026-04-03",{"date":66,"type":34},"2020-03-01",{"date":68,"type":22},"2028-02-24",{"name":40,"class":41},2,{"id":72,"slug":73,"hasResults":11,"nctId":74,"briefTitle":75,"officialTitle":76,"acronym":4,"eligibilityCriteria":77,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":78,"targetDuration":4,"studyType":53,"phases":4,"briefSummary":80,"conditions":81,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":91,"completionDateStruct":92,"leadSponsor":93,"locationsCount":42},"100390741","influenza-vaccination-acei-and-arb-in-the-evolution-of-sars-cov2-infection-100390741","NCT04367883","Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection","Evaluation of Influenza Vaccination and Treatment With ACEI and ARB in the Evolution of SARS-CoV2 Infection","Inclusion Criteria:\n\n* Hospital Admissions at the Hospital of Terrassa from March 1, 2020 for any cause.\n\nExclusion Criteria:\n\n* None.\n* For comparison of percentage of Influenza vaccination, ACEI and ARB vs general population, patients from outside the reference area of the Terrassa Health Consortium would be excluded.",{"count":79,"type":22},3000,"Some authors have proposed the use of the flu vaccine to reduce the severity of COVID-19 cases, while some have proposed the use of ACE Inhibitors (ACEI) or Angiotensin Receptor blockers (ARB), since this virus shares hemagglutinin as a transmission mechanism and acts on the ACE2 enzyme during infection.\n\nOther authors described how none of the elderly patients receiving antihistamines and azythromycin in two nursing homes in Toledo -Spain- during the first wave died or needed hospital admission, even considering that 100% of residents had a positive serological test after that wave. Other authors have described a positive evolution in patients receiving amantadine for their Parkinson's disease.\n\nThe aim is to evaluate whether the admitted patients who are previously vaccinated or those who were already receiving these treatments showed a better evolution.",[82,83,84,85,86,87],"COVID19","Influenza Vaccination","ACE Inhibitors","ARB","Antihistamine Allergy","Amantadine","2026-03-23",{"date":90,"type":34},"2026-03-25",{"date":66,"type":34},{"date":68,"type":22},{"name":40,"class":41},{"id":95,"slug":96,"hasResults":11,"nctId":97,"briefTitle":98,"officialTitle":99,"acronym":4,"eligibilityCriteria":100,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":101,"targetDuration":4,"studyType":53,"phases":4,"briefSummary":103,"conditions":104,"keywords":106,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":110,"lastUpdatePostDateStruct":111,"startDateStruct":113,"completionDateStruct":115,"leadSponsor":117,"locationsCount":42},"100351277","hypofractionated-palliative-radiotherapy-in-patients-with-advanced-non-operable-rectal-cancer-100351277","NCT03853733","Hypofractionated Palliative Radiotherapy in Patients With Advanced Non-operable Rectal Cancer","Palliative Hypofractionated Radiotherapy in Non-operable Rectal Cancer: A Retrospective Study","Inclusion criteria :\n\n1. Patients with rectal or sigmoidal cancer who were not candidates for surgical resection because advanced age, comorbidities, or multiple synchronous metastases at the time of diagnosis\n2. Patients with = or \\> 18 years old\n3. Patients treated with a radiotherapy dose of 39Gy in 13 fractions of 3 Gy\n\nExclusion criteria:\n\n1. Patients with a non rectum or sigma colo-rectal cancer.\n2. Patients with \\\u003C18 years old.\n3. Patients treated with concurrent chemotherapy\n4. Patients candidates for surgical resection after radiotherapy",{"count":102,"type":22},50,"Many patients with rectal cancer were not candidates for surgical resection because advanced age, comorbidities, or multiple synchronous metastases. In this scenario only comfort measures or different palliative radiotherapy regimens are applied, from single doses to treatments lasting several weeks. The aim of this prospective study is to describe the preliminary results of our protocol of hypofractionated palliative radiotherapy in patients with non-operable rectal cancer.",[105],"Rectal Cancer",[107,108,109],"palliative radiotherapy","rectal bleeding","hypofractionated radiotherapy","2026-03-18",{"date":112,"type":34},"2026-03-19",{"date":114,"type":34},"2016-10-01",{"date":116,"type":22},"2027-03-01",{"name":40,"class":41},{"id":119,"slug":120,"hasResults":11,"nctId":121,"briefTitle":122,"officialTitle":122,"acronym":4,"eligibilityCriteria":123,"healthyVolunteers":50,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":124,"targetDuration":4,"studyType":53,"phases":4,"briefSummary":126,"conditions":127,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":129,"lastUpdatePostDateStruct":130,"startDateStruct":131,"completionDateStruct":133,"leadSponsor":135,"locationsCount":42},"100609156","paramedian-incidence-angles-in-spinal-anaesthesia-100609156","NCT07210892","Paramedian Incidence Angles in Spinal Anaesthesia","Inclusion Criteria: patients submitted to spinal anaesthesia -\n\nExclusion Criteria: none\n\n\\-",{"count":125,"type":22},90,"The objective here is to quantify the number of punctures and redirections during routine practice in the anesthesiology department, verify the final angle of incidence and the sac-skin distance by ultrasound, and determine the optimal, maximum, and minimum angles that would have allowed successful punctures. The objective is also to correlate ultrasound and plain X-ray distances, if available. These angles would then be inferred in advance in patients who must undergo spinal anesthesia, assessing whether this prior estimate reduces the number of punctures and redirections.",[128],"Anesthesia; Adverse Effect, Spinal and Epidural","2026-03-16",{"date":110,"type":34},{"date":132,"type":34},"2025-09-30",{"date":134,"type":22},"2028-09-04",{"name":40,"class":41},{"id":137,"slug":138,"hasResults":11,"nctId":139,"briefTitle":140,"officialTitle":141,"acronym":4,"eligibilityCriteria":142,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":143,"targetDuration":144,"studyType":53,"phases":4,"briefSummary":145,"conditions":146,"keywords":148,"overallStatus":152,"whyStopped":4,"lastUpdateSubmitDate":153,"lastUpdatePostDateStruct":154,"startDateStruct":155,"completionDateStruct":157,"leadSponsor":159,"locationsCount":42},"100628881","treatment-of-mechanical-low-back-pain-with-high-intensity-focused-ultrasound-hifu-100628881","NCT07467408","Treatment of Mechanical Low Back Pain With High-Intensity Focused Ultrasound (HIFU)","Prospective Observational Study of the Treatment of Mechanical Low Back Pain With High-Intensity Focused Ultrasound (HIFU) of the Lumbar Medial Branch.","Inclusion Criteria:\n\n* Over 18 years of age.\n* Signed informed consent for data collection.\n* Mechanical low back pain with a positive diagnostic block (\\>30% pain reduction) of the lumbar medial ramus with local anaesthetic.\n\nExclusion Criteria:\n\n* Presence of pain with mixed characteristics or suspected multiple aetiology of the low back pain (e.g. sacroiliac joint involvement).\n* Active systemic infection.\n* Pregnancy.\n* History of spinal surgery at the level of treatment.\n* Presence of tumours, metastatic disease or osteoporosis in the treatment area.\n* Pacemaker or implantable generator carriers.\n* Coagulation disorders or thrombocytopenia.\n* Vertebral fracture or compression at the treatment level.\n* Medical condition contraindicating sedation or the treatment position.",{"count":21,"type":22},"6 Months","High-intensity focused ultrasound (HIFU) is an emerging technology that allows for the targeted thermal ablation of deep tissues in a non-invasive manner, by concentrating acoustic energy on the target nerve, whilst preserving adjacent structures. Recently, open clinical studies have confirmed the feasibility, safety and efficacy of HIFU in patients with lumbar facet syndrome, with clinical response rates similar to those of RFA and no significant complications.\n\nThis observational, prospective, non-interventional study aims to evaluate the clinical efficacy of lumbar medial branch ablation using this technique at 1, 3 and 6 months, as well as to assess patient satisfaction with the procedure. Only clinical data from patients undergoing the procedure in routine clinical practice will be collected.",[147],"Lumbago",[149,150,151],"Chronic Pain","Lumbalgia","HIFU","NOT_YET_RECRUITING","2026-03-12",{"date":129,"type":34},{"date":156,"type":22},"2026-04-01",{"date":158,"type":22},"2026-12-31",{"name":40,"class":41},{"id":161,"slug":162,"hasResults":11,"nctId":163,"briefTitle":164,"officialTitle":164,"acronym":4,"eligibilityCriteria":165,"healthyVolunteers":50,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":166,"targetDuration":4,"studyType":53,"phases":4,"briefSummary":168,"conditions":169,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":171,"lastUpdatePostDateStruct":172,"startDateStruct":174,"completionDateStruct":176,"leadSponsor":178,"locationsCount":42},"100577013","2024-newanescat-register-100577013","NCT06792773","2024 NewAnescat Register","The activity of all the areas in which the anaesthesiologist has some kind of work involvement over 24 hours during 14 days in a year is included through several questionnaires with different formats. Therefore all patients will be included without restriction criteria.",{"count":167,"type":22},13634,"20 years ago, for the first time in Spain, a record was made of all the activity carried out by a medical speciality, called ANESCAT 2003. After 20 years, the increase in healthcare activity has exceeded the expectations and predictions that were made at the time. Therefore, it is necessary to make a new assessment of the work situation in which our speciality finds itself in order to be able to evaluate whether the increase in resources allocated has been proportional and therefore to be able to have objective data with a view to making new demands and planning future needs.",[170],"Anesthesia","2026-02-02",{"date":173,"type":34},"2026-02-04",{"date":175,"type":34},"2025-05-04",{"date":177,"type":22},"2026-05",{"name":40,"class":41},{"id":180,"slug":181,"hasResults":11,"nctId":182,"briefTitle":183,"officialTitle":184,"acronym":185,"eligibilityCriteria":186,"healthyVolunteers":11,"sex":17,"minAge":187,"maxAge":188,"enrollmentInfo":189,"targetDuration":4,"studyType":23,"phases":191,"briefSummary":192,"conditions":193,"keywords":195,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":200,"lastUpdatePostDateStruct":201,"startDateStruct":203,"completionDateStruct":205,"leadSponsor":207,"locationsCount":42},"100596076","immersive-virtual-reality-training-for-improving-cognition-in-adults-with-metabolic-syndrome-100596076","NCT07040748","Immersive Virtual Reality Training for Improving Cognition in Adults With Metabolic Syndrome","Multimodal Immersive Virtual Reality Training for Improving Cognition in Adults With Metabolic Syndrome: A Randomized Clinical Trial","VIRTUAL-METS","Inclusion Criteria:\n\n* Demonstrated criteria for the MetS: central obesity (waist circumference ≥ 94 cm for men or ≥ 80 cm for women) and at least 2 of the criteria described as follow: Triglycerides ≥ 150 mg\u002Fdl or specific treatment of this lipid disorder; HDL-C \\\u003C 40 mg\u002Fdl (men) or \\\u003C 50 mg\u002Fdl (women) or specific treatment of this lipid disorder; Systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg or previously diagnosed hypertension treatment; Basal glycemia ≥ 100 mg\u002Fdl or type 2 diabetes previously diagnosed).\n* Age: between 45 and 70 years old.\n* Subjective cognitive complaints: Subjective Cognitive Decline Questionnaire (≥ 7).\n* Ability to fully understand and speak Spanish or Catalan.\n\nExclusion Criteria:\n\n* Confirmed or suspicion of dementia (MMSE\\\u003C24).\n* Diagnosis of severe psychiatric, neurological, developmental disorders, systemic pathologies, hematological, hormonal, nutritional pathology, and\u002For neoplasm that are known to cause cognitive deficits.\n* Other severe comorbidities considered a probable bias for the study: a cardiac history of unstable angina, recent myocardial infarction within the last 3 months, congestive heart failure, significant heart valve dysfunction, or unstable hypertension; taking medications that could negatively affect cognitive function.\n* Physical, motor, or sensory alterations that impede the neuropsychological examination or the rehabilitation program.","45 Years","70 Years",{"count":190,"type":22},84,[25],"This study aims to evaluate the effectiveness of a multimodal intervention using immersive virtual reality (Virtual-METS) to improve cognitive function in middle-aged adults with metabolic syndrome and subjective cognitive complaints. The intervention combines cognitive training and physical exercise in group sessions over 12 weeks.",[194],"Metabolic Syndrome",[196,197,198,199],"Metabolic syndrome","Cognitive impairment","Virtual Reality","Cognitive Training","2025-06-26",{"date":202,"type":34},"2025-06-27",{"date":204,"type":34},"2025-03-01",{"date":206,"type":22},"2027-04-01",{"name":40,"class":41},{"id":209,"slug":210,"hasResults":11,"nctId":211,"briefTitle":212,"officialTitle":213,"acronym":214,"eligibilityCriteria":215,"healthyVolunteers":11,"sex":216,"minAge":18,"maxAge":217,"enrollmentInfo":218,"targetDuration":4,"studyType":53,"phases":4,"briefSummary":220,"conditions":221,"keywords":224,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":230,"lastUpdatePostDateStruct":231,"startDateStruct":233,"completionDateStruct":235,"leadSponsor":237,"locationsCount":42},"100530260","prostatic-size-reduction-following-of-leuprorelin-acetate-100530260","NCT06184464","Prostatic Size Reduction Following of Leuprorelin Acetate","Prostatic Size Reduction Following the Administration of Leuprorelin Acetate in Localized Prostate Cancer Prior to Radiation Therapy. Pilot Study.","PROSTSIZE","Inclusion Criteria:\n\nMan with Prostate positive biopsy. Able to Ssgned informed consent form. Need of hormonal treatment before start of radiotherapy\n\nExclusion Criteria:\n\nPatients With prostate size of less than 20 cc at diagnosis. Patients With Positive lymph nodes or metastatic prostate cancer disease on imaging studies.\n\nPatients with Previous pelvic radiation therapy.","MALE","95 Years",{"count":219,"type":22},40,"To determine the possible reduction in prostate size following the administration of Leuprelin prior to the application of radiotherapy.",[222,223],"Prostate Cancer Adenocarcinoma","Prostate Adenocarcinoma",[225,226,227,228,229],"reduccion","Eligard","leupreline","radiotherapy","feltes","2024-09-09",{"date":232,"type":34},"2024-09-19",{"date":234,"type":34},"2024-02-02",{"date":236,"type":22},"2024-12-15",{"name":40,"class":41},{"id":239,"slug":240,"hasResults":11,"nctId":241,"briefTitle":242,"officialTitle":242,"acronym":4,"eligibilityCriteria":243,"healthyVolunteers":50,"sex":17,"minAge":244,"maxAge":19,"enrollmentInfo":245,"targetDuration":4,"studyType":23,"phases":247,"briefSummary":248,"conditions":249,"keywords":251,"overallStatus":152,"whyStopped":4,"lastUpdateSubmitDate":259,"lastUpdatePostDateStruct":260,"startDateStruct":262,"completionDateStruct":264,"leadSponsor":266,"locationsCount":4},"100555758","gemas-proyect-gamification-in-nursing-and-medicine-for-simulation-learning-100555758","NCT06516250","GEMAS Proyect. Gamification in Nursing and Medicine for Simulation Learning.","Inclusion Criteria:\n\n* Medical and Nursing Students: Students enrolled in undergraduate programs in medicine (5th and 6th year) or nursing (3rd and 4th year). They may be from various faculties.\n* MIR and EIR Residents: Residents in training in medicine or nursing, from various years of residency and specialties.\n* Geographic Diversity: Participants from different geographic regions or urban areas.\n* Cultural and Linguistic Diversity: Participants from diverse cultures and ethnic groups.\n* Willingness to Participate: Commitment of participants to actively participate in the study.\n\nExclusion Criteria:\n\n* Previous Experience in Similar Cases: Participants who have had previous experience in similar clinical cases or who have received specific training related to the content of the game.\n* Severe Mental or Physical Health Issues: Participants who have severe mental or physical health issues that may affect their ability to participate in the study or adequately understand the content of the game.\n* Conditions Affecting Active Participation: Participants who have conditions that limit their ability to actively participate in the study (states of intoxication, etc.).","20 Years",{"count":246,"type":22},121,[25],"The GEMAS project is based on the creation of a virtual serious game in which, by carrying out clinical cases that simulate real environments and episodes of a hospital emergency service, the aim is to improve and reinforce the knowledge of the participants with the use of a new learning methodology.\n\nThe mapping and creation of several scenarios within the program is carried out, the creation of different characters, both main and secondary, patients and hospital environment, each of them with their graphic representation, characteristics and individual personality.\n\nAfter obtaining the program, which can be used on both computer and mobile platforms, the virtual serious-game will be evaluated with the levels of the Kirkpatrick model to be used as a new learning tool. The degree of satisfaction and usability will be evaluated at the first level, the degree of knowledge acquisition by the participant himself and in comparison with traditional methodologies at the second level, the changes in behavior and transfer of the knowledge learned to the professional field in the third level, and the possibility of knowing the effectiveness of the application for the system will be evaluated. The virtual serious game will allow you to select between the nursing or medicine modality, allowing a greater number of cases to be developed and at the same time, for both stories to be related, so that interdisciplinarity remains intrinsically rooted in the game. The creation of this application will create dynamic learning that will allow greater user satisfaction while learning and a greater degree of knowledge acquisition with respect to traditional methods, ultimately producing changes in work behavior that are favorable for the performance of their profession. .",[250],"Knowledge, Attitudes, Practice",[252,253,254,255,256,257,258],"Serious game","Simulation","Gamification","Knowledge","Learning methodologies","Urgency","Emergency","2024-07-18",{"date":261,"type":34},"2024-07-23",{"date":263,"type":22},"2024-07-22",{"date":265,"type":22},"2027-09-30",{"name":40,"class":41},{"id":268,"slug":269,"hasResults":11,"nctId":270,"briefTitle":271,"officialTitle":271,"acronym":272,"eligibilityCriteria":273,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":274,"targetDuration":4,"studyType":23,"phases":276,"briefSummary":277,"conditions":278,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":281,"lastUpdatePostDateStruct":282,"startDateStruct":284,"completionDateStruct":286,"leadSponsor":288,"locationsCount":42},"100536397","high-voltage-pulsed-radiofrequency-of-the-lumbar-dorsal-root-ganglion-for-the-treatment-of-chronic-lumbar-radicular-and-neuropathic-pain-a-prospective-doble-blinded-and-randomized-controlled-trial-100536397","NCT06264297","High-Voltage Pulsed Radiofrequency of the Lumbar Dorsal Root Ganglion for the Treatment of Chronic Lumbar Radicular and Neuropathic Pain; A Prospective, Doble-blinded and Randomized Controlled Trial","Radiofrequency","Inclusion Criteria:\n\n* Patients over 18 years of age.\n* Unilateral pain radiating to the lower extremity (with or without lumbar pain), which clinically corresponds to the path of the corresponding dermatomes.\n* Correlation between clinical symptoms and lesion observed by magnetic resonance imaging (MRI).\n* Radicular syndrome of three months or more of evolution.\n* Normal or pathological electromyogram (EMG).\n* Pain with neuropathic characteristics confirmed by the DN4 neuropathic pain questionnaire.\n* Patients with a previous positive block diagnosis.\n* Patients who have signed the informed consent document.\n\nExclusion Criteria:\n\n* Patients under 18 years of age.\n* Patients with non-radicular low back pain.\n* MRI not consistent with the patient\\'s symptoms.\n* Patients with peripheral neuropathy of the lower extremities.\n* Patients with a history or current diagnosis of serious mental disorder.\n* Patients with moderate or severe cognitive impairment, or evidence of acute or subacute confusional syndrome.\n* Infection at the puncture site.\n* Coagulation disorders.\n* Pregnant patients.\n* Patients who refuse to sign the informed consent document.\n* Patients allergic to radiological contrast.",{"count":275,"type":22},98,[25],"The management of chronic lumbar radicular and neuropathic pain is complex and the treatment success rates are low. Pulsed radiofrequency (PRF) has been described in these cases. In order to determine whether high-voltage PRF show better results than PRF a prospective, doble-blinded and randomized study is conducted in patients with chronic lumbar radicular and neuropathic pain.",[279,280],"Pulsed Radiofrequency","Lumbar Radiculopathy","2024-02-12",{"date":283,"type":34},"2024-02-16",{"date":285,"type":34},"2023-02-20",{"date":287,"type":22},"2027-12",{"name":40,"class":41},""]